TCL Archive Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds January 29, 2010
TCL Archive NCI Doesn’t Indicate Willingness To Review Large Programs As BSA Recommends. “We’re Celebrating Success,” NCI Director von Eschenbach Says. Intramural Program Isn’t Delivering What It Should, Margaret Tempero Says. March 31, 2006
TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
TCL Archive Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says December 5, 1997
